Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
- PMID: 10589782
Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Abstract
Sterically stabilized liposome is characterized by a surface coating of polyethylene glycol (PEG) or other polymers that can reduce opsonization of the liposome by plasma proteins. It has a higher plasma area under the concentration-time curve (AUC), which is believed to correlate with better therapeutic efficacy. However, the presence of large molecules on the liposomal surface may reduce the interactions of liposomes with cells and hinder entry of liposomes into the tumor tissue. Using a stable liposomal system composed of distearoyl phosphatidylcholine/cholesterol, we examined the effect of PEG (Mr 2000) on the pharmacokinetics and on the efficacy of liposomal doxorubicin with C-26 syngeneic tumor model in BALB/c mice. The plasma AUC of liposomal doxorubicin with 6 mol-% PEG-modified distearoyl phosphatidylethanolamine (PEG-DSPE) was approximately twice that of liposomal doxorubicin without PEG at various dosages, regardless of whether the mice were tumor-bearing. Paradoxically, the group of mice treated with liposomal doxorubicin without PEG had higher tumor doxorubicin concentrations. The 72-h tumor AUC was 1.44 times that of liposomal doxorubicin with 6% PEG-DSPE. The tumor-accumulation efficiency (AUC(Tumor)/AUC(Plasma)) of liposomal doxorubicin without PEG was 0.87, and this was more than twice that of the liposomal doxorubicin with 6% PEG-DSPE (0.31). At a dose of 10 mg/kg, although both liposomal groups were better than the free drug group in terms of clinically relevant parameters, including toxicity, tumor shrinkage, and survival, there was no difference between the two liposomal drug groups. In this stable liposome system, surface coating with PEG offered no benefit for liposomal doxorubicin in the C-26 tumor model. To enhance the therapeutic index of liposomal doxorubicin, simply increasing plasma AUC by surface coating with PEG may not be satisfactory.
Similar articles
-
Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).J Pharmacol Exp Ther. 1997 Mar;280(3):1319-27. J Pharmacol Exp Ther. 1997. PMID: 9067319
-
Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.Cancer. 2001 May 1;91(9):1826-33. Cancer. 2001. PMID: 11335910 Clinical Trial.
-
Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?J Control Release. 2007 Apr 2;118(2):204-15. doi: 10.1016/j.jconrel.2006.12.002. Epub 2006 Dec 8. J Control Release. 2007. PMID: 17239468
-
[PEG-liposome in DDS and clinical studies].Nihon Rinsho. 1998 Mar;56(3):632-7. Nihon Rinsho. 1998. PMID: 9549348 Review. Japanese.
-
Tailoring liposomes for cancer drug delivery: from the bench to the clinic.Ann Biol Clin (Paris). 1993;51(9):811-3. Ann Biol Clin (Paris). 1993. PMID: 8166395 Review.
Cited by
-
Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors.CPT Pharmacometrics Syst Pharmacol. 2012 Nov 21;1(11):e15. doi: 10.1038/psp.2012.16. CPT Pharmacometrics Syst Pharmacol. 2012. PMID: 23835797 Free PMC article.
-
Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages.Int J Mol Sci. 2014 Dec 11;15(12):22960-77. doi: 10.3390/ijms151222960. Int J Mol Sci. 2014. PMID: 25514405 Free PMC article.
-
Poly(ethylene glycol) with observable shedding.Angew Chem Int Ed Engl. 2010 Sep 3;49(37):6567-71. doi: 10.1002/anie.201001868. Angew Chem Int Ed Engl. 2010. PMID: 20677297 Free PMC article.
-
Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.Open Nanomed J. 2011 Jan 1;3:38-64. doi: 10.2174/1875933501103010038. Open Nanomed J. 2011. PMID: 23807899 Free PMC article.
-
Biodegradable micelles capable of mannose-mediated targeted drug delivery to cancer cells.Macromol Rapid Commun. 2015 Mar;36(5):483-9. doi: 10.1002/marc.201400650. Epub 2015 Jan 23. Macromol Rapid Commun. 2015. PMID: 25619623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources